82 related articles for article (PubMed ID: 7783331)
1. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
Marcante R; Cavedon G
Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
[TBL] [Abstract][Full Text] [Related]
5. [Serum soluble CD4 and CD8 levels in Kawasaki disease].
Motohashi T
Arerugi; 1992 Feb; 41(2 Pt 1):140-7. PubMed ID: 1567283
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of serum sICAM-1 and sCD4 & sCD8 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):596-8. PubMed ID: 15515547
[TBL] [Abstract][Full Text] [Related]
7. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
8. [Levels of soluble CD4 and soluble CD8 in patients with sarcoidosis].
Sato S; Ina Y; Takada K; Sato T; Ito S; Sahashi K; Yamamoto M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Feb; 32(2):117-24. PubMed ID: 8164397
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble CD4 and CD8 in patients with chronic viral hepatitis.
Onji M; Doi Y; Miyaoka H; Masumoto T; Horiike N; Ohta Y
Hepatogastroenterology; 1994 Aug; 41(4):377-9. PubMed ID: 7959575
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
[TBL] [Abstract][Full Text] [Related]
11. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
[TBL] [Abstract][Full Text] [Related]
12. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble CD4 and CD8 levels in Kawasaki disease.
Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
[TBL] [Abstract][Full Text] [Related]
14. Lower concentration of serum soluble CD8 in severe Hashimoto's disease.
Yamamoto N; Watanabe M; Matsuzuka F; Miyauchi A; Iwatani Y
Clin Exp Immunol; 2004 Sep; 137(3):601-5. PubMed ID: 15320913
[TBL] [Abstract][Full Text] [Related]
15. An assessment of concentrations of soluble CD4 and CD8 receptors in serum before and after surgical treatment in patients with chronic maxillary sinusitis.
Olszewski J; Chudzik W; Wiśniewski K; Miłoński J; Matyja R
Am J Rhinol; 2003; 17(3):123-6. PubMed ID: 12862398
[TBL] [Abstract][Full Text] [Related]
16. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
17. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
19. [Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis].
Motohashi T
Arerugi; 1993 Aug; 42(8):926-33. PubMed ID: 7902699
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
